IHAM
SVRA icon

Integral Health Asset Management’s Savara SVRA Stock Holding History

Integral Health Asset Management’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.28M Buy
+600,000
New +$3.34M 0.16% 81

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Integral Health Asset Management's SVRA Position: Q1 2026 in Review

Integral Health Asset Management opened a new position in Savara (SVRA) in Q1 2026: 600,000 shares worth $3.28M. The stake represents 0.16% of the portfolio and ranks #81 among its holdings.

185 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

  • Integral Health Asset Management held 600,000 shares of Savara worth $3.28M as of Q1 2026.
  • Savara was a new Integral Health Asset Management position in Q1 2026.
  • Savara made up 0.16% of Integral Health Asset Management's portfolio in Q1 2026, its #81 holding.
  • 185 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.